S2

Simcere Pharmaceutical Group LtdFRA Simcere Pharmaceutical Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

2.018

Small

Exchange

XFRA - Deutsche Boerse AG

View Section: Price ratios

Simcere Pharmaceutical Statements

S2

Data from Simcere Pharmaceutical`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

CNY - Chinese yuan

Last reporting period:

31 Dec, 2023

Next reporting period:

28 Jun, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

19 Aug, 2024

Simcere Pharmaceutical Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

CNY (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-12-31
%

3 228.48

-4.5 %

100

805.62

25

2 422.85

-5.4 %

75

787.25

24.4

1 351.8

41.9

2 064

-6.3 %

63.9

358.85

0 %

11.1

-1 912.99

-59.3

0

-1 585.14

-168.2 %

-49.1

-25.258

-0.8

-1 559.89

-168.6 %

-48.3

-0.6

2 598.12

2023-06-30
%

3 379.33

-6.8 %

100

818.03

24.2

2 561.3

-10.3 %

75.8

775.89

23

1 503

44.5

2 202.44

-9 %

65.2

358.86

-17.5 %

10.6

1 176.25

34.8

0

2 325.18

178.9 %

68.8

51.346

1.5

2 274.65

162.3 %

67.3

0.869

2 618.95

2022-12-31
%

3 624.43

34.3 %

100

770.03

21.2

2 854.4

33.2 %

78.8

1 076.75

29.7

1 637.09

45.2

2 419.21

37.3 %

66.7

435.19

14.5 %

12

409.11

11.3

0

833.73

1487.4 %

23

-31.08

-0.9

867.08

1259.4 %

23.9

0.331

2 622.38

2022-06-30
%

2 699.65

-6.3 %

100

557.37

20.6

2 142.28

-5.1 %

79.4

651.54

24.1

1 197.78

44.4

1 762.19

-15.6 %

65.3

380.09

126.6 %

14.1

-327.56

-12.1

0

52.523

-94 %

1.9

-9.398

-0.3

63.784

-93.3 %

2.4

0.024

2 618.37

2021-12-31
%

2 879.72

35.8 %

100

623.01

21.6

2 256.71

35.7 %

78.4

789.92

27.4

1 385.9

48.1

2 088.98

30.8 %

72.5

167.73

155.7 %

5.8

709.75

24.6

0

879.96

68.6 %

30.6

-64.069

-2.2

949.28

70.2 %

33

0.363

2 614.07

2021-06-30
%

2 120

-17.9 %

100

456.98

21.6

1 663.03

-19.7 %

78.4

626.8

29.6

1 033.29

48.7

1 597.42

-14.9 %

75.4

65.602

-66.3 %

3.1

-46.641

-2.2

0

521.84

-10.1 %

24.6

-33.055

-1.6

557.81

15.2 %

26.3

0.214

2 608.64

2020-12-31
%

2 583.31

34.2 %

100

511.8

19.8

2 071.51

34.8 %

80.2

687.9

26.6

1 159.88

44.9

1 876.6

52.2 %

72.6

194.91

-35.9 %

7.5

376.79

14.6

0

580.36

158.2 %

22.5

100.9

3.9

484.02

160.9 %

18.7

0.198

2 440.16

2020-06-30
%

1 925.41

100

388.13

20.2

1 537.28

79.8

454.09

23.6

821.97

42.7

1 232.98

64

304.3

15.8

-79.826

-4.1

0

224.73

11.7

39.898

2.1

185.52

9.6

0.079

2 345.12

View Section: Balance Sheet